Brief: Venus Remedies Says US FDA Grants QIDP Designation To Venus Remedies' VRP-034
17/04/2025 06:41
April 17 (Reuters) - Venus Remedies Ltd VENR.NS: VENUS REMEDIES LTD - US FDA GRANTS QIDP DESIGNATION TO VENUS REMEDIES' VRP-034 Source text: ID:nBSE93HMNh Further company coverage: VENR.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage